REBECCA BARAJAS: Open Payments
NPI 1972061216 · VISALIA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$495 in 13 payments from 5 companies in 2025. Trend: 2023 $63 · 2024 $0 · 2025 $495
Food & beverage: $495
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $256 |
| ABIOMED | 4 | $120 |
| Lilly USA, LLC | 3 | $61 |
| Sumitomo Pharma America, Inc. | 2 | $43 |
| ABBVIE INC. | 1 | $16 |
Products named: Ozempic, Wegovy, GEMTESA, ZEPBOUND, JARDIANCE, LINZESS.
Industry payments across CA — which companies pay providers there.
